Defining Clinical Obesity
Definition and diagnostic criteria of clinical obesityRubino, Francesco et al.The Lancet Diabetes & Endocrinology, Volume 13, Issue 3, 221 – 262 The Lancet Diabetes & Endocrinology Commission’s comprehensive work on defining and diagnosing clinical obesity, distinguishing it from mere excess adiposity. A large international expert group, including patient representatives, utilized a Delphi-like consensus process to establish objective criteria for clinical obesity in […]
How To Increase Metabolism & GLP-1 Levels Through The Gut Microbiome
Plus, what to add to your grocery list this week
WATCH | Ozempic, Mounjaro linked to vision loss in diabetics
Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the risk of a severe form of vision loss among diabetics, affecting daily activities such as reading and driving.
Weight loss drugs linked to higher risk of eye damage in diabetic patients. Study finds medicines such as Ozempic associated with greater risk of developing age-related macular degeneration. Patients who had been taking GLP-1 RAs for more than 30 months had more than three times the risk.
submitted by /u/mvea [link] [comments]
A Study Linked GLP-1 Drugs to What Ocular Condition?
(MedPage Today) — You passed medical training, now see if you can pass our weekly quiz